1. Home
  2. APGE vs HAFN Comparison

APGE vs HAFN Comparison

Compare APGE & HAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • HAFN
  • Stock Information
  • Founded
  • APGE 2022
  • HAFN 2012
  • Country
  • APGE United States
  • HAFN Singapore
  • Employees
  • APGE N/A
  • HAFN N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • HAFN
  • Sector
  • APGE Health Care
  • HAFN
  • Exchange
  • APGE Nasdaq
  • HAFN Nasdaq
  • Market Cap
  • APGE 2.1B
  • HAFN 2.1B
  • IPO Year
  • APGE 2023
  • HAFN N/A
  • Fundamental
  • Price
  • APGE $37.81
  • HAFN $5.05
  • Analyst Decision
  • APGE Strong Buy
  • HAFN Strong Buy
  • Analyst Count
  • APGE 4
  • HAFN 1
  • Target Price
  • APGE $91.33
  • HAFN $6.50
  • AVG Volume (30 Days)
  • APGE 579.0K
  • HAFN 1.6M
  • Earning Date
  • APGE 05-20-2025
  • HAFN 05-27-2025
  • Dividend Yield
  • APGE N/A
  • HAFN 22.97%
  • EPS Growth
  • APGE N/A
  • HAFN N/A
  • EPS
  • APGE N/A
  • HAFN 1.50
  • Revenue
  • APGE N/A
  • HAFN $2,868,647,000.00
  • Revenue This Year
  • APGE N/A
  • HAFN N/A
  • Revenue Next Year
  • APGE $743.14
  • HAFN $1.48
  • P/E Ratio
  • APGE N/A
  • HAFN $3.36
  • Revenue Growth
  • APGE N/A
  • HAFN 7.37
  • 52 Week Low
  • APGE $26.20
  • HAFN $3.61
  • 52 Week High
  • APGE $63.50
  • HAFN $8.99
  • Technical
  • Relative Strength Index (RSI)
  • APGE 53.99
  • HAFN N/A
  • Support Level
  • APGE $36.59
  • HAFN N/A
  • Resistance Level
  • APGE $41.05
  • HAFN N/A
  • Average True Range (ATR)
  • APGE 2.25
  • HAFN 0.00
  • MACD
  • APGE 0.15
  • HAFN 0.00
  • Stochastic Oscillator
  • APGE 62.72
  • HAFN 0.00

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About HAFN Hafnia Limited Common Shares

Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk.

Share on Social Networks: